Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma ...Middle East

OSLO, Norway, May 25, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces initial promising data from the Archer-1 Phase 1b trial investigating Betalutin® (177Lu lilotomab satetraxetan) in combination with rituximab (RTX) in second-line follicular lymphoma (2L FL). The...

Hence then, the article about nordic nanovector announces update from archer 1 phase 1b trial of betalutin in combination with rituximab in 2l follicular lymphoma was published today ( Tuesday 25/05/2021 - 08:43 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma )

Also on site :

• Suspect in deadly San Jose police shooting identified
• Details emerge in crime spree that ended in deadly shootout with San Jose police
• Zelensky is ‘a man in a desperate position’ – Orban